Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 74257-00-4 | MDL No. : | MFCD00009754 |
Formula : | C11H12N4O4S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SFYDWLYPIXHPML-UHFFFAOYSA-N |
M.W : | 296.30 | Pubchem ID : | 716901 |
Synonyms : |
|
Num. heavy atoms : | 20 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.27 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 72.81 |
TPSA : | 119.05 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.34 cm/s |
Log Po/w (iLOGP) : | 1.89 |
Log Po/w (XLOGP3) : | 2.49 |
Log Po/w (WLOGP) : | 2.43 |
Log Po/w (MLOGP) : | 2.6 |
Log Po/w (SILICOS-IT) : | -0.95 |
Consensus Log Po/w : | 1.69 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.45 |
Solubility : | 0.104 mg/ml ; 0.000351 mol/l |
Class : | Soluble |
Log S (Ali) : | -4.64 |
Solubility : | 0.00686 mg/ml ; 0.0000232 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -3.01 |
Solubility : | 0.288 mg/ml ; 0.000971 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.33 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
48% | With triethylamine In 1,4-dioxane for 1.5 h; Cooling with ice | An oven dried 1.0 l round-bottomedflask containing a magnetic stir bar was equipped with a Claisen adapter. 3-Nitro-1,2,4-triazole (19.5 g, 0.171 mol), dry dioxane (200 ml) and triethylamine (1.0 equiv., 17.3 g,0.171 mol) was transferred to the reaction flask and the solution was cooled in an ice-bathwith magnetic stirring.47 The Claisen adapter was fitted with a 200 ml pressure-equalizingaddition funnel, containing a dioxane solution (150 ml) of mesitylenesulfonyl chloride(37.4 g, 0.171 mol). The solution of mesitylenesulfonyl chloride was added dropwise overa period of approx. 0.5 h and the final suspension was stirred for an additional 1 h andthen warmed to rt. After removal of the precipitated Et3N·HCl by filtration, the filtratewas concentrated in vacuo to give a yellow solid, which was dissolved in dichloromethane(150 ml) and the solution was washed with water (150 ml).48 The organic layer was driedover anhydrous Na2SO4 and evaporated in vacuo to give a yellow solid. Recrystallizationfrom boiling toluene (20–30 ml) followed by washing with ice-cold toluene and dryingovernight at 1.9 mmHg, provided 24–25 g (46percent–48percent) of the title compound as light yellow solid,49 mp. 131C–133C (lit.37 130C–132C). Rf = 0.23 (20percent hexane in CH2Cl2, UV);1H NMR (300 MHz, CDCl3): δ 8.84 (s, 1H), 7.07 (s, 2H), 2.69 (s, 6H), 2.34 (s, 3H);13C NMR (75 MHz, CDCl3): δ 162.9, 147.5, 145.2, 142.5, 133.0, 127.9, 23.2, 21.3; IR(solid): 3126, 2983, 2947, 1597.Anal. Calcd. for C11H12N4O4S: C, 44.59; H, 4.08; N, 18.91. Found: C, 44.69; H,3.88; N, 18.72. The purity of the product (96percent) established by RP-HPLC, tR = 8.41 min(254 nm). |